Janoshik-verified peptide research from Dubai. Retatrutide trial data, GLP-1 landscape updates, COA audits, regulatory trackers. https://remypeptides.com/feed.xml 2026-05-13T06:30:00Z Remy Peptides https://remypeptides.com/ (C) 2026 Remy Peptides. For Research Use Only. https://remypeptides.com/favicon.svg https://remypeptides.com/icon-512.png https://remypeptides.com/research/is-retatrutide-approved 2026-05-13T06:30:00Z 2026-03-09T00:00:00Z Remy Peptides

Retatrutide FDA approval status, May 2026: still Phase 3, no NDA filed. TRIUMPH-1/-2/-4 readouts, dose schedule, and what to watch before filing.

https://remypeptides.com/research/are-peptides-legal 2026-05-13T06:30:00Z 2026-03-17T00:00:00Z Remy Peptides

Are peptides legal in 2026? Australia (TGA Schedule 4), US (FDA), UAE (MoHAP), UK, EU, Canada compared. Research-use vs human-use distinction explained.

https://remypeptides.com/research/obesity-drug-pipeline-timeline-2026 2026-05-13T06:30:00Z 2026-03-09T00:00:00Z Remy Peptides

Novo Nordisk & Eli Lilly obesity drug pipeline 2026: Phase 3 readouts, FDA decision windows, NDA filings across CagriSema, Retatrutide, Foundayo, Survodutide.

https://remypeptides.com/research/is-survodutide-approved 2026-05-13T06:30:00Z 2026-03-09T00:00:00Z Remy Peptides

No. Survodutide is not FDA approved as of May 2026. SYNCHRONIZE-1 Phase 3 read out April 28: 16.6% weight loss at 76 weeks. Full data at ADA June 2026.

https://remypeptides.com/research/is-orforglipron-approved 2026-05-13T06:30:00Z 2026-03-09T00:00:00Z Remy Peptides

Orforglipron (Foundayo) FDA approval status, May 2026: first non-peptide oral GLP-1 for obesity, approved April 1, 2026. ATTAIN-1 data and what

https://remypeptides.com/research/is-cagrisema-approved 2026-05-13T06:30:00Z 2026-03-09T00:00:00Z Remy Peptides

CagriSema FDA approval status, May 2026: not yet approved. Novo filed Dec 2025; FDA decision expected Q4 2026. See trial readouts and timeline.

https://remypeptides.com/research/obesity-drug-approval-tracker-2026 2026-05-13T06:30:00Z 2026-03-09T00:00:00Z Remy Peptides

2026 obesity drug tracker: Novo Nordisk & Eli Lilly Phase 3 status, FDA approvals, NDA filings. Retatrutide, CagriSema, Foundayo, Survodutide at a glance.

https://remypeptides.com/research/is-oral-vk2735-approved 2026-05-13T06:30:00Z 2026-03-09T00:00:00Z Remy Peptides

Viking

https://remypeptides.com/research/retatrutide-dosage-guide 2026-05-13T06:30:00Z 2026-03-06T00:00:00Z Remy Peptides

Retatrutide starting dose: 2mg/week. TRIUMPH-1 titration schedule (4/9/12mg maintenance), dose-hold rules, and protocol notes for in-vitro research.

https://remypeptides.com/research/zenagamtide-amycretin-glp1-amylin 2026-05-13T06:30:00Z 2026-03-06T00:00:00Z Remy Peptides

Zenagamtide (amycretin) May 2026: 14.5% weight loss at 36 weeks (Phase 2), GLP-1/amylin dual-agonist mechanism, AMAZE Phase 3 obesity trials enrolling.

https://remypeptides.com/research/best-obesity-drug-2026 2026-05-10T08:00:00Z 2026-03-09T00:00:00Z Remy Peptides

Best obesity drug 2026: 8-drug guide comparing approved (Wegovy, Zepbound, Foundayo) and pipeline (retatrutide, CagriSema) by efficacy, route, and tolerability.

https://remypeptides.com/research/glp1-side-effects-online-communities-2026 2026-05-10T00:00:00Z 2026-04-24T00:00:00Z Remy Peptides

March 2026 arXiv study mined 410,198 Reddit posts from 67,008 GLP-1 users — what community side-effect signals add to clinical trial data.

https://remypeptides.com/research/retatrutide-triumph-trial-tracker 2026-05-10T00:00:00Z 2026-03-16T00:00:00Z Remy Peptides

Retatrutide TRIUMPH-4 results date, weight-loss data + knee OA readout, full Phase 3 TRIUMPH-1/-2/-3/-6 schedule, TRANSCEND-T2D-1 A1C data, NDA timeline.

https://remypeptides.com/research/foundayo-orforglipron-fda-approved 2026-05-10T00:00:00Z 2026-04-06T00:00:00Z Remy Peptides

Foundayo (orforglipron) self-pay: $149–$349/month or $25/month with insurance. FDA approved April 1, 2026; ATTAIN-1 trial showed 12.4% weight loss.

https://remypeptides.com/research/retatrutide-clinical-trials-uae 2026-05-10T00:00:00Z 2026-04-11T00:00:00Z Remy Peptides

Retatrutide UAE approval status, May 2026: not approved, Phase 3 TRIUMPH ongoing. Registry site check, UAE framework, and research-use sourcing context.

https://remypeptides.com/research/glp1-medications-uae-availability-cost 2026-05-10T00:00:00Z 2026-02-26T00:00:00Z Remy Peptides

Foundayo / orforglipron UAE: EDE-approved April 3, 2026 (FDA Apr 1) — no AED reference price yet. Plus 2026 Ozempic, Mounjaro, Wegovy prices.

https://remypeptides.com/research/survodutide-vs-retatrutide 2026-05-10T00:00:00Z 2026-03-09T00:00:00Z Remy Peptides

Survodutide hits ~19% weight loss (Phase 2), retatrutide hits 28.7% (Phase 3). Both use glucagon — but the triple agonist pulls ahead. Full comparison.

https://remypeptides.com/research/blood-tests-before-starting-glp1-peptides 2026-05-09T00:00:00Z 2026-05-09T00:00:00Z Remy Peptides

Plain-English lab checklist before GLP-1s and peptides: HbA1c, CMP, lipids, CBC, thyroid, lipase, pregnancy testing, and peptide-specific add-ons.

https://remypeptides.com/research/retatrutide-pen-clicks-guide 2026-05-09T00:00:00Z 2026-04-03T00:00:00Z Remy Peptides

Exact mg-to-click lookup for the 30mg retatrutide pen: 0.1mg per click, 1mg = 10 clicks, 60-click max dial, plus split-dose and pen-duration tables.

https://remypeptides.com/research/are-peptides-legal-dubai 2026-05-09T00:00:00Z 2026-04-11T00:00:00Z Remy Peptides

Is it safe to buy peptides online in Dubai? See what UAE medicine and customs rules cover, where research-use listings fit, and how to verify a supplier.

https://remypeptides.com/research/retatrutide-dubai 2026-05-08T08:00:00Z 2026-03-06T00:00:00Z Remy Peptides

Retatrutide in Dubai: 5 pen and vial formats, Janoshik-verified COAs on flagship batches, AED tiers for context, cold-chain logistics. Research use only.

https://remypeptides.com/research/retatrutide-pen-guide 2026-05-08T00:00:00Z 2026-03-14T00:00:00Z Remy Peptides

Step-by-step retatrutide pen use: prime, dial, inject, store. 0.1mg per click, 300-click pen, 28-day in-use window. Research use only.

https://remypeptides.com/research/retatrutide-profile 2026-05-07T00:00:00Z 2026-04-22T00:00:00Z Remy Peptides

Eli Lilly

https://remypeptides.com/research/retatrutide-half-life 2026-05-04T08:00:00Z 2026-04-14T00:00:00Z Remy Peptides

Retatrutide half-life is about 6 days in published Lilly research. See the PK data, why once-weekly dosing works, and how long washout may take.

https://remypeptides.com/buy-retatrutide-dubai 2026-05-04T08:00:00Z 2026-03-30T00:00:00Z Remy Peptides

Research-only retatrutide supplier verification in Dubai under MoHAP 17/2022 — COA checks, pricing, format selection, cold-chain handling.

https://remypeptides.com/research/weight-loss-injections-comparison-guide 2026-05-04T08:00:00Z 2026-03-10T00:00:00Z Remy Peptides

Weight loss injections Dubai price guide for 2026: compare Mounjaro, Wegovy, Ozempic, Saxenda, and research-use retatrutide by monthly cost, access, and data.

https://remypeptides.com/research/what-are-peptides 2026-05-03T00:00:00Z 2026-04-09T00:00:00Z Remy Peptides

Beginner

https://remypeptides.com/research/peptide-raw-powder-sourcing-2026 2026-05-03T00:00:00Z 2026-03-08T00:00:00Z Remy Peptides

How to vet peptide powder suppliers in 2026: HPLC CoA red flags, third-party testing standards, cold-chain logistics & B2B pricing benchmarks.

https://remypeptides.com/research/peptide-coa-hplc-purity-guide 2026-05-03T00:00:00Z 2026-04-24T00:00:00Z Remy Peptides

How to read a peptide Certificate of Analysis: HPLC purity, assay, LC-MS identity, endotoxin, TFA, heavy metals, and Janoshik batch verification.

https://remypeptides.com/research/retatrutide-research-hub 2026-05-03T00:00:00Z 2026-05-03T00:00:00Z Remy Peptides

Retatrutide research hub: what the molecule is, Phase 3 status, dose math, pen guides, approval tracking, and UAE verification routes.